News + Filings Transactions Holdings
|
WELLINGTON MANAGEMENT GROUP LLP
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 1,045,289 | -95,871 | 26,456,264,000 | -10,300,499,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 1,141,160 | 808,483 | 36,756,763,000 | 36,747,780,000 | $32,210.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 332,677 | -11,790 | 8,983,000 | 4,223,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 344,467 | -321 | 4,760,000 | -1,963,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 344,788 | -694,124 | 6,723,000 | -10,232,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 1,038,912 | -178,181 | 16,955,000 | -16,953,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 1,217,093 | -1,553,147 | 33,908,000 | -48,201,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 2,770,240 | -65,451 | 82,109,000 | 2,852,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 2,835,691 | -432,426 | 79,257,000 | -13,362,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 3,268,117 | -294,474 | 92,619,000 | 3,056,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 3,562,591 | -194,207 | 89,563,000 | -2,178,000 | $25.14 |
| 07/31/2020 | Revance Therapeutics, Inc. | RVNC | 3,743,700 | -13,098 | 87,902,076 | -3,838,924 | $23.48 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 3,756,798 | -1,869,621 | 91,741,000 | 8,470,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 5,626,419 | -161,626 | 83,271,000 | -10,669,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 5,788,045 | 376,573 | 93,940,000 | 23,591,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 5,411,472 | -291,995 | 70,349,000 | -3,624,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 5,703,467 | -40,667 | 73,973,000 | -16,555,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 5,744,134 | 1,432,790 | 90,528,000 | 3,741,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 4,311,344 | 296,001 | 86,787,000 | -12,994,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 4,015,343 | 232,756 | 99,781,000 | -4,052,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 3,782,587 | -31,447 | 103,833,000 | -13,639,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 3,814,034 | 240,884 | 117,472,000 | -10,268,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 3,573,150 | 1,231,640 | 127,740,000 | 63,232,000 | $35.75 |
| 12/29/2017 | Revance Therapeutics, Inc. | RVNC | 3,573,150 | 1,231,640 | 127,740,113 | 63,232,113 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 2,341,510 | 401,698 | 64,508,000 | 13,296,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 1,939,812 | -151,995 | 51,212,000 | 7,702,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 2,091,807 | -57,871 | 43,510,000 | -989,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 2,149,678 | -263,662 | 44,499,000 | 5,379,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 2,413,340 | 2,413,340 | 39,120,000 | 39,120,000 | $16.21 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 2,338,548 | 2,338,548 | 31,805,000 | 31,805,000 | $13.60 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 1,651,426 | 1,130,248 | 28,834,000 | 11,031,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 521,178 | 431,936 | 17,803,000 | 15,147,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 89,242 | -19,380 | 2,656,000 | -818,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 108,622 | 860 | 3,474,000 | 1,240,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 107,762 | -52,450 | 2,234,000 | -480,000 | $20.73 |
| << Prev Next >> |
|